The compound methyl-B-cyclodextrin reduces insulin resistance, disease that silently attacks to 22 percent of Chilean people. This discovery was made by a group of researchers of the Nemesis Ring of the University of Chile, led by Dr. Paola Llanos. This news was posted on January 10 in daily Las Ultimas Noticias…  

During a Meeting that brought together more than forty researchers NEMESIS scientists presented research advances in the areas of cancer, diabetes and cardiovascular diseases Of particular interest were recent findings related to a new drug for the treatment of insulin resistance and the importance of exercise in treatment of many chronic pathologies.  Non-communicable diseases are […]

Dates: October 5-9th, 2015 Place: Advanced Center for Chronic Diseases (ACCDiS) Facultad Ciencias Químicas y Farmacéuticas, Universidad de Chile, Olivos 1007, Santiago, Chile 2015  Organizer: Sergio Lavandero, PhD (ACCDiS, Universidad de Chile) Coordinators: Mario Chiong, PhD (ACCDiS, Universidad de Chile) Rodrigo Troncoso, PhD (ACCDiS, Universidad de Chile) Lorena García, PhD (ACCDiS, Universidad de Chile, Chile) Topics Energy Metabolism Organelle and […]

ANNUAL MEETING RING Rancho El Añil Friday December 19, 2014   9:00 to 10:00: COFFEE BREAK – WELCOME I. Block moderator Dr. Enrique Jaimovich 9:00 to 9:30: Reception 9:30 to 9:50: Dr. Andrew Quest: Greetings and brief summary of the activity. 9:50 to 10:10: Dr. Sergio Washerman                   […]